Global Neurotherapy Market Growth 2025-2031
The global Neurotherapy market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Neurotherapy, also known as neurofeedback or EEG biofeedback, is a therapeutic approach that utilizes real-time monitoring of brainwave patterns to provide feedback and promote self-regulation of brain activity. It involves the use of specialized equipment to record electrical signals from the brain, which are then processed and presented visually or audibly to the individual receiving therapy. Neurotherapy aims to train and enhance specific brainwave patterns associated with improved cognitive function, emotional regulation, and overall well-being.
United States market for Neurotherapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Neurotherapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Neurotherapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Neurotherapy players cover Medtronic, Boston Scientific Corporation, Abbott, Nexalin Technology, Alpha-Stim, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the ?Neurotherapy Industry Forecast? looks at past sales and reviews total world Neurotherapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Neurotherapy sales for 2025 through 2031. With Neurotherapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurotherapy industry.
This Insight Report provides a comprehensive analysis of the global Neurotherapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurotherapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Neurotherapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurotherapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurotherapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurotherapy market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
is the 10-year outlook for the global Neurotherapy market?
factors are driving Neurotherapy market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Neurotherapy market opportunities vary by end market size?
How does Neurotherapy break out by Type, by Application?
Neurotherapy, also known as neurofeedback or EEG biofeedback, is a therapeutic approach that utilizes real-time monitoring of brainwave patterns to provide feedback and promote self-regulation of brain activity. It involves the use of specialized equipment to record electrical signals from the brain, which are then processed and presented visually or audibly to the individual receiving therapy. Neurotherapy aims to train and enhance specific brainwave patterns associated with improved cognitive function, emotional regulation, and overall well-being.
United States market for Neurotherapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Neurotherapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Neurotherapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Neurotherapy players cover Medtronic, Boston Scientific Corporation, Abbott, Nexalin Technology, Alpha-Stim, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the ?Neurotherapy Industry Forecast? looks at past sales and reviews total world Neurotherapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Neurotherapy sales for 2025 through 2031. With Neurotherapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurotherapy industry.
This Insight Report provides a comprehensive analysis of the global Neurotherapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurotherapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Neurotherapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurotherapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurotherapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurotherapy market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Internal Treatment
- External Treatment
- Parkinson's Disease
- Epilepsy
- Migraine
- Depression
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Medtronic
- Boston Scientific Corporation
- Abbott
- Nexalin Technology
- Alpha-Stim
- Neuro-Fitness
- LivaNova
- Beijing Pins Medical
- SceneRay
- RISHENA
- Znion HK
is the 10-year outlook for the global Neurotherapy market?
factors are driving Neurotherapy market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Neurotherapy market opportunities vary by end market size?
How does Neurotherapy break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurotherapy Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Neurotherapy by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Neurotherapy by Country/Region, 2020, 2024 & 2031
2.2 Neurotherapy Segment by Type
2.2.1 Internal Treatment
2.2.2 External Treatment
2.3 Neurotherapy Sales by Type
2.3.1 Global Neurotherapy Sales Market Share by Type (2020-2025)
2.3.2 Global Neurotherapy Revenue and Market Share by Type (2020-2025)
2.3.3 Global Neurotherapy Sale Price by Type (2020-2025)
2.4 Neurotherapy Segment by Application
2.4.1 Parkinson's Disease
2.4.2 Epilepsy
2.4.3 Migraine
2.4.4 Depression
2.4.5 Others
2.5 Neurotherapy Sales by Application
2.5.1 Global Neurotherapy Sale Market Share by Application (2020-2025)
2.5.2 Global Neurotherapy Revenue and Market Share by Application (2020-2025)
2.5.3 Global Neurotherapy Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Neurotherapy Breakdown Data by Company
3.1.1 Global Neurotherapy Annual Sales by Company (2020-2025)
3.1.2 Global Neurotherapy Sales Market Share by Company (2020-2025)
3.2 Global Neurotherapy Annual Revenue by Company (2020-2025)
3.2.1 Global Neurotherapy Revenue by Company (2020-2025)
3.2.2 Global Neurotherapy Revenue Market Share by Company (2020-2025)
3.3 Global Neurotherapy Sale Price by Company
3.4 Key Manufacturers Neurotherapy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neurotherapy Product Location Distribution
3.4.2 Players Neurotherapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NEUROTHERAPY BY GEOGRAPHIC REGION
4.1 World Historic Neurotherapy Market Size by Geographic Region (2020-2025)
4.1.1 Global Neurotherapy Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Neurotherapy Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Neurotherapy Market Size by Country/Region (2020-2025)
4.2.1 Global Neurotherapy Annual Sales by Country/Region (2020-2025)
4.2.2 Global Neurotherapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Neurotherapy Sales Growth
4.4 APAC Neurotherapy Sales Growth
4.5 Europe Neurotherapy Sales Growth
4.6 Middle East & Africa Neurotherapy Sales Growth
5 AMERICAS
5.1 Americas Neurotherapy Sales by Country
5.1.1 Americas Neurotherapy Sales by Country (2020-2025)
5.1.2 Americas Neurotherapy Revenue by Country (2020-2025)
5.2 Americas Neurotherapy Sales by Type (2020-2025)
5.3 Americas Neurotherapy Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurotherapy Sales by Region
6.1.1 APAC Neurotherapy Sales by Region (2020-2025)
6.1.2 APAC Neurotherapy Revenue by Region (2020-2025)
6.2 APAC Neurotherapy Sales by Type (2020-2025)
6.3 APAC Neurotherapy Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Neurotherapy by Country
7.1.1 Europe Neurotherapy Sales by Country (2020-2025)
7.1.2 Europe Neurotherapy Revenue by Country (2020-2025)
7.2 Europe Neurotherapy Sales by Type (2020-2025)
7.3 Europe Neurotherapy Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurotherapy by Country
8.1.1 Middle East & Africa Neurotherapy Sales by Country (2020-2025)
8.1.2 Middle East & Africa Neurotherapy Revenue by Country (2020-2025)
8.2 Middle East & Africa Neurotherapy Sales by Type (2020-2025)
8.3 Middle East & Africa Neurotherapy Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neurotherapy
10.3 Manufacturing Process Analysis of Neurotherapy
10.4 Industry Chain Structure of Neurotherapy
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neurotherapy Distributors
11.3 Neurotherapy Customer
12 WORLD FORECAST REVIEW FOR NEUROTHERAPY BY GEOGRAPHIC REGION
12.1 Global Neurotherapy Market Size Forecast by Region
12.1.1 Global Neurotherapy Forecast by Region (2026-2031)
12.1.2 Global Neurotherapy Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Neurotherapy Forecast by Type (2026-2031)
12.7 Global Neurotherapy Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Neurotherapy Product Portfolios and Specifications
13.1.3 Medtronic Neurotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Boston Scientific Corporation
13.2.1 Boston Scientific Corporation Company Information
13.2.2 Boston Scientific Corporation Neurotherapy Product Portfolios and Specifications
13.2.3 Boston Scientific Corporation Neurotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Boston Scientific Corporation Main Business Overview
13.2.5 Boston Scientific Corporation Latest Developments
13.3 Abbott
13.3.1 Abbott Company Information
13.3.2 Abbott Neurotherapy Product Portfolios and Specifications
13.3.3 Abbott Neurotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Abbott Main Business Overview
13.3.5 Abbott Latest Developments
13.4 Nexalin Technology
13.4.1 Nexalin Technology Company Information
13.4.2 Nexalin Technology Neurotherapy Product Portfolios and Specifications
13.4.3 Nexalin Technology Neurotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Nexalin Technology Main Business Overview
13.4.5 Nexalin Technology Latest Developments
13.5 Alpha-Stim
13.5.1 Alpha-Stim Company Information
13.5.2 Alpha-Stim Neurotherapy Product Portfolios and Specifications
13.5.3 Alpha-Stim Neurotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Alpha-Stim Main Business Overview
13.5.5 Alpha-Stim Latest Developments
13.6 Neuro-Fitness
13.6.1 Neuro-Fitness Company Information
13.6.2 Neuro-Fitness Neurotherapy Product Portfolios and Specifications
13.6.3 Neuro-Fitness Neurotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Neuro-Fitness Main Business Overview
13.6.5 Neuro-Fitness Latest Developments
13.7 LivaNova
13.7.1 LivaNova Company Information
13.7.2 LivaNova Neurotherapy Product Portfolios and Specifications
13.7.3 LivaNova Neurotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 LivaNova Main Business Overview
13.7.5 LivaNova Latest Developments
13.8 Beijing Pins Medical
13.8.1 Beijing Pins Medical Company Information
13.8.2 Beijing Pins Medical Neurotherapy Product Portfolios and Specifications
13.8.3 Beijing Pins Medical Neurotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Beijing Pins Medical Main Business Overview
13.8.5 Beijing Pins Medical Latest Developments
13.9 SceneRay
13.9.1 SceneRay Company Information
13.9.2 SceneRay Neurotherapy Product Portfolios and Specifications
13.9.3 SceneRay Neurotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 SceneRay Main Business Overview
13.9.5 SceneRay Latest Developments
13.10 RISHENA
13.10.1 RISHENA Company Information
13.10.2 RISHENA Neurotherapy Product Portfolios and Specifications
13.10.3 RISHENA Neurotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 RISHENA Main Business Overview
13.10.5 RISHENA Latest Developments
13.11 Znion HK
13.11.1 Znion HK Company Information
13.11.2 Znion HK Neurotherapy Product Portfolios and Specifications
13.11.3 Znion HK Neurotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Znion HK Main Business Overview
13.11.5 Znion HK Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurotherapy Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Neurotherapy by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Neurotherapy by Country/Region, 2020, 2024 & 2031
2.2 Neurotherapy Segment by Type
2.2.1 Internal Treatment
2.2.2 External Treatment
2.3 Neurotherapy Sales by Type
2.3.1 Global Neurotherapy Sales Market Share by Type (2020-2025)
2.3.2 Global Neurotherapy Revenue and Market Share by Type (2020-2025)
2.3.3 Global Neurotherapy Sale Price by Type (2020-2025)
2.4 Neurotherapy Segment by Application
2.4.1 Parkinson's Disease
2.4.2 Epilepsy
2.4.3 Migraine
2.4.4 Depression
2.4.5 Others
2.5 Neurotherapy Sales by Application
2.5.1 Global Neurotherapy Sale Market Share by Application (2020-2025)
2.5.2 Global Neurotherapy Revenue and Market Share by Application (2020-2025)
2.5.3 Global Neurotherapy Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Neurotherapy Breakdown Data by Company
3.1.1 Global Neurotherapy Annual Sales by Company (2020-2025)
3.1.2 Global Neurotherapy Sales Market Share by Company (2020-2025)
3.2 Global Neurotherapy Annual Revenue by Company (2020-2025)
3.2.1 Global Neurotherapy Revenue by Company (2020-2025)
3.2.2 Global Neurotherapy Revenue Market Share by Company (2020-2025)
3.3 Global Neurotherapy Sale Price by Company
3.4 Key Manufacturers Neurotherapy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neurotherapy Product Location Distribution
3.4.2 Players Neurotherapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NEUROTHERAPY BY GEOGRAPHIC REGION
4.1 World Historic Neurotherapy Market Size by Geographic Region (2020-2025)
4.1.1 Global Neurotherapy Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Neurotherapy Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Neurotherapy Market Size by Country/Region (2020-2025)
4.2.1 Global Neurotherapy Annual Sales by Country/Region (2020-2025)
4.2.2 Global Neurotherapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Neurotherapy Sales Growth
4.4 APAC Neurotherapy Sales Growth
4.5 Europe Neurotherapy Sales Growth
4.6 Middle East & Africa Neurotherapy Sales Growth
5 AMERICAS
5.1 Americas Neurotherapy Sales by Country
5.1.1 Americas Neurotherapy Sales by Country (2020-2025)
5.1.2 Americas Neurotherapy Revenue by Country (2020-2025)
5.2 Americas Neurotherapy Sales by Type (2020-2025)
5.3 Americas Neurotherapy Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurotherapy Sales by Region
6.1.1 APAC Neurotherapy Sales by Region (2020-2025)
6.1.2 APAC Neurotherapy Revenue by Region (2020-2025)
6.2 APAC Neurotherapy Sales by Type (2020-2025)
6.3 APAC Neurotherapy Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Neurotherapy by Country
7.1.1 Europe Neurotherapy Sales by Country (2020-2025)
7.1.2 Europe Neurotherapy Revenue by Country (2020-2025)
7.2 Europe Neurotherapy Sales by Type (2020-2025)
7.3 Europe Neurotherapy Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurotherapy by Country
8.1.1 Middle East & Africa Neurotherapy Sales by Country (2020-2025)
8.1.2 Middle East & Africa Neurotherapy Revenue by Country (2020-2025)
8.2 Middle East & Africa Neurotherapy Sales by Type (2020-2025)
8.3 Middle East & Africa Neurotherapy Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neurotherapy
10.3 Manufacturing Process Analysis of Neurotherapy
10.4 Industry Chain Structure of Neurotherapy
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neurotherapy Distributors
11.3 Neurotherapy Customer
12 WORLD FORECAST REVIEW FOR NEUROTHERAPY BY GEOGRAPHIC REGION
12.1 Global Neurotherapy Market Size Forecast by Region
12.1.1 Global Neurotherapy Forecast by Region (2026-2031)
12.1.2 Global Neurotherapy Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Neurotherapy Forecast by Type (2026-2031)
12.7 Global Neurotherapy Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Neurotherapy Product Portfolios and Specifications
13.1.3 Medtronic Neurotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Boston Scientific Corporation
13.2.1 Boston Scientific Corporation Company Information
13.2.2 Boston Scientific Corporation Neurotherapy Product Portfolios and Specifications
13.2.3 Boston Scientific Corporation Neurotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Boston Scientific Corporation Main Business Overview
13.2.5 Boston Scientific Corporation Latest Developments
13.3 Abbott
13.3.1 Abbott Company Information
13.3.2 Abbott Neurotherapy Product Portfolios and Specifications
13.3.3 Abbott Neurotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Abbott Main Business Overview
13.3.5 Abbott Latest Developments
13.4 Nexalin Technology
13.4.1 Nexalin Technology Company Information
13.4.2 Nexalin Technology Neurotherapy Product Portfolios and Specifications
13.4.3 Nexalin Technology Neurotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Nexalin Technology Main Business Overview
13.4.5 Nexalin Technology Latest Developments
13.5 Alpha-Stim
13.5.1 Alpha-Stim Company Information
13.5.2 Alpha-Stim Neurotherapy Product Portfolios and Specifications
13.5.3 Alpha-Stim Neurotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Alpha-Stim Main Business Overview
13.5.5 Alpha-Stim Latest Developments
13.6 Neuro-Fitness
13.6.1 Neuro-Fitness Company Information
13.6.2 Neuro-Fitness Neurotherapy Product Portfolios and Specifications
13.6.3 Neuro-Fitness Neurotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Neuro-Fitness Main Business Overview
13.6.5 Neuro-Fitness Latest Developments
13.7 LivaNova
13.7.1 LivaNova Company Information
13.7.2 LivaNova Neurotherapy Product Portfolios and Specifications
13.7.3 LivaNova Neurotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 LivaNova Main Business Overview
13.7.5 LivaNova Latest Developments
13.8 Beijing Pins Medical
13.8.1 Beijing Pins Medical Company Information
13.8.2 Beijing Pins Medical Neurotherapy Product Portfolios and Specifications
13.8.3 Beijing Pins Medical Neurotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Beijing Pins Medical Main Business Overview
13.8.5 Beijing Pins Medical Latest Developments
13.9 SceneRay
13.9.1 SceneRay Company Information
13.9.2 SceneRay Neurotherapy Product Portfolios and Specifications
13.9.3 SceneRay Neurotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 SceneRay Main Business Overview
13.9.5 SceneRay Latest Developments
13.10 RISHENA
13.10.1 RISHENA Company Information
13.10.2 RISHENA Neurotherapy Product Portfolios and Specifications
13.10.3 RISHENA Neurotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 RISHENA Main Business Overview
13.10.5 RISHENA Latest Developments
13.11 Znion HK
13.11.1 Znion HK Company Information
13.11.2 Znion HK Neurotherapy Product Portfolios and Specifications
13.11.3 Znion HK Neurotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Znion HK Main Business Overview
13.11.5 Znion HK Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Neurotherapy Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Neurotherapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Internal Treatment
Table 4. Major Players of External Treatment
Table 5. Global Neurotherapy Sales by Type (2020-2025) & (K Units)
Table 6. Global Neurotherapy Sales Market Share by Type (2020-2025)
Table 7. Global Neurotherapy Revenue by Type (2020-2025) & ($ million)
Table 8. Global Neurotherapy Revenue Market Share by Type (2020-2025)
Table 9. Global Neurotherapy Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global Neurotherapy Sale by Application (2020-2025) & (K Units)
Table 11. Global Neurotherapy Sale Market Share by Application (2020-2025)
Table 12. Global Neurotherapy Revenue by Application (2020-2025) & ($ million)
Table 13. Global Neurotherapy Revenue Market Share by Application (2020-2025)
Table 14. Global Neurotherapy Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Neurotherapy Sales by Company (2020-2025) & (K Units)
Table 16. Global Neurotherapy Sales Market Share by Company (2020-2025)
Table 17. Global Neurotherapy Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Neurotherapy Revenue Market Share by Company (2020-2025)
Table 19. Global Neurotherapy Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Neurotherapy Producing Area Distribution and Sales Area
Table 21. Players Neurotherapy Products Offered
Table 22. Neurotherapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Neurotherapy Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Neurotherapy Sales Market Share Geographic Region (2020-2025)
Table 27. Global Neurotherapy Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Neurotherapy Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Neurotherapy Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Neurotherapy Sales Market Share by Country/Region (2020-2025)
Table 31. Global Neurotherapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Neurotherapy Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Neurotherapy Sales by Country (2020-2025) & (K Units)
Table 34. Americas Neurotherapy Sales Market Share by Country (2020-2025)
Table 35. Americas Neurotherapy Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Neurotherapy Sales by Type (2020-2025) & (K Units)
Table 37. Americas Neurotherapy Sales by Application (2020-2025) & (K Units)
Table 38. APAC Neurotherapy Sales by Region (2020-2025) & (K Units)
Table 39. APAC Neurotherapy Sales Market Share by Region (2020-2025)
Table 40. APAC Neurotherapy Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Neurotherapy Sales by Type (2020-2025) & (K Units)
Table 42. APAC Neurotherapy Sales by Application (2020-2025) & (K Units)
Table 43. Europe Neurotherapy Sales by Country (2020-2025) & (K Units)
Table 44. Europe Neurotherapy Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Neurotherapy Sales by Type (2020-2025) & (K Units)
Table 46. Europe Neurotherapy Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Neurotherapy Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Neurotherapy Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Neurotherapy Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Neurotherapy Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Neurotherapy
Table 52. Key Market Challenges & Risks of Neurotherapy
Table 53. Key Industry Trends of Neurotherapy
Table 54. Neurotherapy Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Neurotherapy Distributors List
Table 57. Neurotherapy Customer List
Table 58. Global Neurotherapy Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Neurotherapy Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Neurotherapy Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Neurotherapy Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Neurotherapy Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Neurotherapy Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Neurotherapy Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Neurotherapy Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Neurotherapy Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Neurotherapy Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Neurotherapy Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Neurotherapy Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Neurotherapy Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Neurotherapy Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Medtronic Basic Information, Neurotherapy Manufacturing Base, Sales Area and Its Competitors
Table 73. Medtronic Neurotherapy Product Portfolios and Specifications
Table 74. Medtronic Neurotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Medtronic Main Business
Table 76. Medtronic Latest Developments
Table 77. Boston Scientific Corporation Basic Information, Neurotherapy Manufacturing Base, Sales Area and Its Competitors
Table 78. Boston Scientific Corporation Neurotherapy Product Portfolios and Specifications
Table 79. Boston Scientific Corporation Neurotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Boston Scientific Corporation Main Business
Table 81. Boston Scientific Corporation Latest Developments
Table 82. Abbott Basic Information, Neurotherapy Manufacturing Base, Sales Area and Its Competitors
Table 83. Abbott Neurotherapy Product Portfolios and Specifications
Table 84. Abbott Neurotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Abbott Main Business
Table 86. Abbott Latest Developments
Table 87. Nexalin Technology Basic Information, Neurotherapy Manufacturing Base, Sales Area and Its Competitors
Table 88. Nexalin Technology Neurotherapy Product Portfolios and Specifications
Table 89. Nexalin Technology Neurotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Nexalin Technology Main Business
Table 91. Nexalin Technology Latest Developments
Table 92. Alpha-Stim Basic Information, Neurotherapy Manufacturing Base, Sales Area and Its Competitors
Table 93. Alpha-Stim Neurotherapy Product Portfolios and Specifications
Table 94. Alpha-Stim Neurotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Alpha-Stim Main Business
Table 96. Alpha-Stim Latest Developments
Table 97. Neuro-Fitness Basic Information, Neurotherapy Manufacturing Base, Sales Area and Its Competitors
Table 98. Neuro-Fitness Neurotherapy Product Portfolios and Specifications
Table 99. Neuro-Fitness Neurotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Neuro-Fitness Main Business
Table 101. Neuro-Fitness Latest Developments
Table 102. LivaNova Basic Information, Neurotherapy Manufacturing Base, Sales Area and Its Competitors
Table 103. LivaNova Neurotherapy Product Portfolios and Specifications
Table 104. LivaNova Neurotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. LivaNova Main Business
Table 106. LivaNova Latest Developments
Table 107. Beijing Pins Medical Basic Information, Neurotherapy Manufacturing Base, Sales Area and Its Competitors
Table 108. Beijing Pins Medical Neurotherapy Product Portfolios and Specifications
Table 109. Beijing Pins Medical Neurotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Beijing Pins Medical Main Business
Table 111. Beijing Pins Medical Latest Developments
Table 112. SceneRay Basic Information, Neurotherapy Manufacturing Base, Sales Area and Its Competitors
Table 113. SceneRay Neurotherapy Product Portfolios and Specifications
Table 114. SceneRay Neurotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. SceneRay Main Business
Table 116. SceneRay Latest Developments
Table 117. RISHENA Basic Information, Neurotherapy Manufacturing Base, Sales Area and Its Competitors
Table 118. RISHENA Neurotherapy Product Portfolios and Specifications
Table 119. RISHENA Neurotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. RISHENA Main Business
Table 121. RISHENA Latest Developments
Table 122. Znion HK Basic Information, Neurotherapy Manufacturing Base, Sales Area and Its Competitors
Table 123. Znion HK Neurotherapy Product Portfolios and Specifications
Table 124. Znion HK Neurotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. Znion HK Main Business
Table 126. Znion HK Latest Developments
Table 1. Neurotherapy Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Neurotherapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Internal Treatment
Table 4. Major Players of External Treatment
Table 5. Global Neurotherapy Sales by Type (2020-2025) & (K Units)
Table 6. Global Neurotherapy Sales Market Share by Type (2020-2025)
Table 7. Global Neurotherapy Revenue by Type (2020-2025) & ($ million)
Table 8. Global Neurotherapy Revenue Market Share by Type (2020-2025)
Table 9. Global Neurotherapy Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global Neurotherapy Sale by Application (2020-2025) & (K Units)
Table 11. Global Neurotherapy Sale Market Share by Application (2020-2025)
Table 12. Global Neurotherapy Revenue by Application (2020-2025) & ($ million)
Table 13. Global Neurotherapy Revenue Market Share by Application (2020-2025)
Table 14. Global Neurotherapy Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Neurotherapy Sales by Company (2020-2025) & (K Units)
Table 16. Global Neurotherapy Sales Market Share by Company (2020-2025)
Table 17. Global Neurotherapy Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Neurotherapy Revenue Market Share by Company (2020-2025)
Table 19. Global Neurotherapy Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Neurotherapy Producing Area Distribution and Sales Area
Table 21. Players Neurotherapy Products Offered
Table 22. Neurotherapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Neurotherapy Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Neurotherapy Sales Market Share Geographic Region (2020-2025)
Table 27. Global Neurotherapy Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Neurotherapy Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Neurotherapy Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Neurotherapy Sales Market Share by Country/Region (2020-2025)
Table 31. Global Neurotherapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Neurotherapy Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Neurotherapy Sales by Country (2020-2025) & (K Units)
Table 34. Americas Neurotherapy Sales Market Share by Country (2020-2025)
Table 35. Americas Neurotherapy Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Neurotherapy Sales by Type (2020-2025) & (K Units)
Table 37. Americas Neurotherapy Sales by Application (2020-2025) & (K Units)
Table 38. APAC Neurotherapy Sales by Region (2020-2025) & (K Units)
Table 39. APAC Neurotherapy Sales Market Share by Region (2020-2025)
Table 40. APAC Neurotherapy Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Neurotherapy Sales by Type (2020-2025) & (K Units)
Table 42. APAC Neurotherapy Sales by Application (2020-2025) & (K Units)
Table 43. Europe Neurotherapy Sales by Country (2020-2025) & (K Units)
Table 44. Europe Neurotherapy Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Neurotherapy Sales by Type (2020-2025) & (K Units)
Table 46. Europe Neurotherapy Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Neurotherapy Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Neurotherapy Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Neurotherapy Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Neurotherapy Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Neurotherapy
Table 52. Key Market Challenges & Risks of Neurotherapy
Table 53. Key Industry Trends of Neurotherapy
Table 54. Neurotherapy Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Neurotherapy Distributors List
Table 57. Neurotherapy Customer List
Table 58. Global Neurotherapy Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Neurotherapy Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Neurotherapy Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Neurotherapy Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Neurotherapy Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Neurotherapy Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Neurotherapy Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Neurotherapy Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Neurotherapy Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Neurotherapy Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Neurotherapy Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Neurotherapy Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Neurotherapy Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Neurotherapy Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Medtronic Basic Information, Neurotherapy Manufacturing Base, Sales Area and Its Competitors
Table 73. Medtronic Neurotherapy Product Portfolios and Specifications
Table 74. Medtronic Neurotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Medtronic Main Business
Table 76. Medtronic Latest Developments
Table 77. Boston Scientific Corporation Basic Information, Neurotherapy Manufacturing Base, Sales Area and Its Competitors
Table 78. Boston Scientific Corporation Neurotherapy Product Portfolios and Specifications
Table 79. Boston Scientific Corporation Neurotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Boston Scientific Corporation Main Business
Table 81. Boston Scientific Corporation Latest Developments
Table 82. Abbott Basic Information, Neurotherapy Manufacturing Base, Sales Area and Its Competitors
Table 83. Abbott Neurotherapy Product Portfolios and Specifications
Table 84. Abbott Neurotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Abbott Main Business
Table 86. Abbott Latest Developments
Table 87. Nexalin Technology Basic Information, Neurotherapy Manufacturing Base, Sales Area and Its Competitors
Table 88. Nexalin Technology Neurotherapy Product Portfolios and Specifications
Table 89. Nexalin Technology Neurotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Nexalin Technology Main Business
Table 91. Nexalin Technology Latest Developments
Table 92. Alpha-Stim Basic Information, Neurotherapy Manufacturing Base, Sales Area and Its Competitors
Table 93. Alpha-Stim Neurotherapy Product Portfolios and Specifications
Table 94. Alpha-Stim Neurotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Alpha-Stim Main Business
Table 96. Alpha-Stim Latest Developments
Table 97. Neuro-Fitness Basic Information, Neurotherapy Manufacturing Base, Sales Area and Its Competitors
Table 98. Neuro-Fitness Neurotherapy Product Portfolios and Specifications
Table 99. Neuro-Fitness Neurotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Neuro-Fitness Main Business
Table 101. Neuro-Fitness Latest Developments
Table 102. LivaNova Basic Information, Neurotherapy Manufacturing Base, Sales Area and Its Competitors
Table 103. LivaNova Neurotherapy Product Portfolios and Specifications
Table 104. LivaNova Neurotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. LivaNova Main Business
Table 106. LivaNova Latest Developments
Table 107. Beijing Pins Medical Basic Information, Neurotherapy Manufacturing Base, Sales Area and Its Competitors
Table 108. Beijing Pins Medical Neurotherapy Product Portfolios and Specifications
Table 109. Beijing Pins Medical Neurotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Beijing Pins Medical Main Business
Table 111. Beijing Pins Medical Latest Developments
Table 112. SceneRay Basic Information, Neurotherapy Manufacturing Base, Sales Area and Its Competitors
Table 113. SceneRay Neurotherapy Product Portfolios and Specifications
Table 114. SceneRay Neurotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. SceneRay Main Business
Table 116. SceneRay Latest Developments
Table 117. RISHENA Basic Information, Neurotherapy Manufacturing Base, Sales Area and Its Competitors
Table 118. RISHENA Neurotherapy Product Portfolios and Specifications
Table 119. RISHENA Neurotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. RISHENA Main Business
Table 121. RISHENA Latest Developments
Table 122. Znion HK Basic Information, Neurotherapy Manufacturing Base, Sales Area and Its Competitors
Table 123. Znion HK Neurotherapy Product Portfolios and Specifications
Table 124. Znion HK Neurotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. Znion HK Main Business
Table 126. Znion HK Latest Developments
LIST OF FIGURES
Figure 1. Picture of Neurotherapy
Figure 2. Neurotherapy Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neurotherapy Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Neurotherapy Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Neurotherapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Neurotherapy Sales Market Share by Country/Region (2024)
Figure 10. Neurotherapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Internal Treatment
Figure 12. Product Picture of External Treatment
Figure 13. Global Neurotherapy Sales Market Share by Type in 2025
Figure 14. Global Neurotherapy Revenue Market Share by Type (2020-2025)
Figure 15. Neurotherapy Consumed in Parkinson's Disease
Figure 16. Global Neurotherapy Market: Parkinson's Disease (2020-2025) & (K Units)
Figure 17. Neurotherapy Consumed in Epilepsy
Figure 18. Global Neurotherapy Market: Epilepsy (2020-2025) & (K Units)
Figure 19. Neurotherapy Consumed in Migraine
Figure 20. Global Neurotherapy Market: Migraine (2020-2025) & (K Units)
Figure 21. Neurotherapy Consumed in Depression
Figure 22. Global Neurotherapy Market: Depression (2020-2025) & (K Units)
Figure 23. Neurotherapy Consumed in Others
Figure 24. Global Neurotherapy Market: Others (2020-2025) & (K Units)
Figure 25. Global Neurotherapy Sale Market Share by Application (2024)
Figure 26. Global Neurotherapy Revenue Market Share by Application in 2025
Figure 27. Neurotherapy Sales by Company in 2025 (K Units)
Figure 28. Global Neurotherapy Sales Market Share by Company in 2025
Figure 29. Neurotherapy Revenue by Company in 2025 ($ millions)
Figure 30. Global Neurotherapy Revenue Market Share by Company in 2025
Figure 31. Global Neurotherapy Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Neurotherapy Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Neurotherapy Sales 2020-2025 (K Units)
Figure 34. Americas Neurotherapy Revenue 2020-2025 ($ millions)
Figure 35. APAC Neurotherapy Sales 2020-2025 (K Units)
Figure 36. APAC Neurotherapy Revenue 2020-2025 ($ millions)
Figure 37. Europe Neurotherapy Sales 2020-2025 (K Units)
Figure 38. Europe Neurotherapy Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Neurotherapy Sales 2020-2025 (K Units)
Figure 40. Middle East & Africa Neurotherapy Revenue 2020-2025 ($ millions)
Figure 41. Americas Neurotherapy Sales Market Share by Country in 2025
Figure 42. Americas Neurotherapy Revenue Market Share by Country (2020-2025)
Figure 43. Americas Neurotherapy Sales Market Share by Type (2020-2025)
Figure 44. Americas Neurotherapy Sales Market Share by Application (2020-2025)
Figure 45. United States Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Neurotherapy Sales Market Share by Region in 2025
Figure 50. APAC Neurotherapy Revenue Market Share by Region (2020-2025)
Figure 51. APAC Neurotherapy Sales Market Share by Type (2020-2025)
Figure 52. APAC Neurotherapy Sales Market Share by Application (2020-2025)
Figure 53. China Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 57. India Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Neurotherapy Sales Market Share by Country in 2025
Figure 61. Europe Neurotherapy Revenue Market Share by Country (2020-2025)
Figure 62. Europe Neurotherapy Sales Market Share by Type (2020-2025)
Figure 63. Europe Neurotherapy Sales Market Share by Application (2020-2025)
Figure 64. Germany Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 65. France Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Neurotherapy Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Neurotherapy Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Neurotherapy Sales Market Share by Application (2020-2025)
Figure 72. Egypt Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Neurotherapy in 2025
Figure 78. Manufacturing Process Analysis of Neurotherapy
Figure 79. Industry Chain Structure of Neurotherapy
Figure 80. Channels of Distribution
Figure 81. Global Neurotherapy Sales Market Forecast by Region (2026-2031)
Figure 82. Global Neurotherapy Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Neurotherapy Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Neurotherapy Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Neurotherapy Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Neurotherapy Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Neurotherapy
Figure 2. Neurotherapy Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neurotherapy Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Neurotherapy Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Neurotherapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Neurotherapy Sales Market Share by Country/Region (2024)
Figure 10. Neurotherapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Internal Treatment
Figure 12. Product Picture of External Treatment
Figure 13. Global Neurotherapy Sales Market Share by Type in 2025
Figure 14. Global Neurotherapy Revenue Market Share by Type (2020-2025)
Figure 15. Neurotherapy Consumed in Parkinson's Disease
Figure 16. Global Neurotherapy Market: Parkinson's Disease (2020-2025) & (K Units)
Figure 17. Neurotherapy Consumed in Epilepsy
Figure 18. Global Neurotherapy Market: Epilepsy (2020-2025) & (K Units)
Figure 19. Neurotherapy Consumed in Migraine
Figure 20. Global Neurotherapy Market: Migraine (2020-2025) & (K Units)
Figure 21. Neurotherapy Consumed in Depression
Figure 22. Global Neurotherapy Market: Depression (2020-2025) & (K Units)
Figure 23. Neurotherapy Consumed in Others
Figure 24. Global Neurotherapy Market: Others (2020-2025) & (K Units)
Figure 25. Global Neurotherapy Sale Market Share by Application (2024)
Figure 26. Global Neurotherapy Revenue Market Share by Application in 2025
Figure 27. Neurotherapy Sales by Company in 2025 (K Units)
Figure 28. Global Neurotherapy Sales Market Share by Company in 2025
Figure 29. Neurotherapy Revenue by Company in 2025 ($ millions)
Figure 30. Global Neurotherapy Revenue Market Share by Company in 2025
Figure 31. Global Neurotherapy Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Neurotherapy Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Neurotherapy Sales 2020-2025 (K Units)
Figure 34. Americas Neurotherapy Revenue 2020-2025 ($ millions)
Figure 35. APAC Neurotherapy Sales 2020-2025 (K Units)
Figure 36. APAC Neurotherapy Revenue 2020-2025 ($ millions)
Figure 37. Europe Neurotherapy Sales 2020-2025 (K Units)
Figure 38. Europe Neurotherapy Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Neurotherapy Sales 2020-2025 (K Units)
Figure 40. Middle East & Africa Neurotherapy Revenue 2020-2025 ($ millions)
Figure 41. Americas Neurotherapy Sales Market Share by Country in 2025
Figure 42. Americas Neurotherapy Revenue Market Share by Country (2020-2025)
Figure 43. Americas Neurotherapy Sales Market Share by Type (2020-2025)
Figure 44. Americas Neurotherapy Sales Market Share by Application (2020-2025)
Figure 45. United States Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Neurotherapy Sales Market Share by Region in 2025
Figure 50. APAC Neurotherapy Revenue Market Share by Region (2020-2025)
Figure 51. APAC Neurotherapy Sales Market Share by Type (2020-2025)
Figure 52. APAC Neurotherapy Sales Market Share by Application (2020-2025)
Figure 53. China Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 57. India Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Neurotherapy Sales Market Share by Country in 2025
Figure 61. Europe Neurotherapy Revenue Market Share by Country (2020-2025)
Figure 62. Europe Neurotherapy Sales Market Share by Type (2020-2025)
Figure 63. Europe Neurotherapy Sales Market Share by Application (2020-2025)
Figure 64. Germany Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 65. France Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Neurotherapy Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Neurotherapy Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Neurotherapy Sales Market Share by Application (2020-2025)
Figure 72. Egypt Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Neurotherapy Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Neurotherapy in 2025
Figure 78. Manufacturing Process Analysis of Neurotherapy
Figure 79. Industry Chain Structure of Neurotherapy
Figure 80. Channels of Distribution
Figure 81. Global Neurotherapy Sales Market Forecast by Region (2026-2031)
Figure 82. Global Neurotherapy Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Neurotherapy Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Neurotherapy Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Neurotherapy Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Neurotherapy Revenue Market Share Forecast by Application (2026-2031)
